Drugs / Influenza virus vaccine (split virion, inactivated)
Influenza virus vaccine (split virion, inactivated)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01138397 | Jun → Jul 2010 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT01121822 | May → Jun 2010 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza virus vaccine (split virion, inactivated) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01121822 ↗ |
| Modality | Vaccine | “influenza vaccine (split virion, inactivated)” NCT01121822 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01121822 ↗ |